Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


05.04.2021

3 Antimicrob Agents Chemother
1 Emerg Infect Dis
3 Int J Antimicrob Agents
1 J Infect Dis
1 Lancet
1 Nature
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. GIL-MARQUES ML, Jacoby GA, Hooper DC
    Analyzing possible native functions of the quinolone resistance gene qnr in Vibrio vulnificus.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00232.
    PubMed         Abstract available

  2. SICELOFF AT, Ohta N, Norman KN, Loneragan GH, et al
    Antimicrobial resistance hidden within multi-serovar Salmonella populations.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00048.
    PubMed         Abstract available

  3. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    PubMed         Abstract available


    Emerg Infect Dis

  4. PATEL A, Emerick M, Cabunoc MK, Williams MH, et al
    Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units.
    Emerg Infect Dis. 2021;27.
    PubMed         Abstract available


    Int J Antimicrob Agents

  5. MAEHANA S, Eda R, Hirabayashi A, Niida N, et al
    nNatural factories that manufacture antimicrobial resistance genes: quadruple blaGES-carrying plasmids in Aeromonas and Pseudomonas species.
    Int J Antimicrob Agents. 2021 Mar 28:106327.
    PubMed        

  6. HAGIHARA M, Kato H, Sugano T, Okade H, et al
    Pharmacodynamic evaluation of meropenem, cefepime, and aztreonam combined with a novel beta-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh in
    Int J Antimicrob Agents. 2021 Mar 28:106330.
    PubMed         Abstract available

  7. YEAGER SD, Oliver JE, Shorman MA, Wright LR, et al
    Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections.
    Int J Antimicrob Agents. 2021 Mar 27:106329.
    PubMed         Abstract available


    J Infect Dis

  8. GUTHRIE JL, Teatero S, Hirai S, Fortuna A, et al
    Genomic Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Hospitalized Individuals in Ontario, Canada.
    J Infect Dis. 2020;222:2071-2081.
    PubMed         Abstract available


    Lancet


  9. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    PubMed         Abstract available


    Nature

  10. SINGH KS, Sharma R, Reddy PAN, Vonteddu P, et al
    IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance.
    Nature. 2021;589:597-602.
    PubMed         Abstract available


    PLoS One

  11. YOO R, So H, Seo E, Kim M, et al
    Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    PLoS One. 2021;16:e0247714.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: